The Use of Stem Cells as a Potential Treatment Method for Selected Neurodegenerative Diseases: Review.

Cell Mol Neurobiol · 2023 · PMC10333383 · PMID 37027074

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A pre-specified analysis of participants' response rate at 28 weeks was 35% MSC-NTF and 16% placebo.Significant improvements in cerebrospinal biomarkers of neuroinflammation, neurodegeneration, and neurotrophic factor support were observed with MSC-NTF, with the placebo unchanged.The treatment was well tolerated by patients but did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.